大众科技
大衆科技
대음과기
DAZHONG KEJI
2013年
12期
132-133
,共2页
脑安胶囊%气虚血瘀型%中风恢复期%疗效观察
腦安膠囊%氣虛血瘀型%中風恢複期%療效觀察
뇌안효낭%기허혈어형%중풍회복기%료효관찰
Efficacy%brain Capsule%oi and blood%stroke recovery
目的:观察脑安胶囊治疗中风恢复期气虚血瘀型的临床疗效。方法:将中风恢复期气虚血瘀型患者76例随机分治疗组39例和对照组37例,对照组给予常规对症治疗,包括抗凝,抗血小板聚集,脑保护,控制血糖、血压等;治疗组在常规治疗的同时给予脑安胶囊口服2# bid,连续治疗30d。观察治疗前后2组患者临床疗效和神经功能缺损(NDS)评分变化情况。结果:治疗组显著进步率(61.6%)及总进步率(94.9%)均分别高于对照组显著进步率(32.4%)及总进步率(75.7%),两组差异有统计学意义(P<0.05)。两组治疗后神经功能缺损评分均下降,而治疗组NDS评分下降优于对照组(P<0.05)。结论:脑安胶囊在治疗中风恢复期气虚血瘀型疗效肯定。
目的:觀察腦安膠囊治療中風恢複期氣虛血瘀型的臨床療效。方法:將中風恢複期氣虛血瘀型患者76例隨機分治療組39例和對照組37例,對照組給予常規對癥治療,包括抗凝,抗血小闆聚集,腦保護,控製血糖、血壓等;治療組在常規治療的同時給予腦安膠囊口服2# bid,連續治療30d。觀察治療前後2組患者臨床療效和神經功能缺損(NDS)評分變化情況。結果:治療組顯著進步率(61.6%)及總進步率(94.9%)均分彆高于對照組顯著進步率(32.4%)及總進步率(75.7%),兩組差異有統計學意義(P<0.05)。兩組治療後神經功能缺損評分均下降,而治療組NDS評分下降優于對照組(P<0.05)。結論:腦安膠囊在治療中風恢複期氣虛血瘀型療效肯定。
목적:관찰뇌안효낭치료중풍회복기기허혈어형적림상료효。방법:장중풍회복기기허혈어형환자76례수궤분치료조39례화대조조37례,대조조급여상규대증치료,포괄항응,항혈소판취집,뇌보호,공제혈당、혈압등;치료조재상규치료적동시급여뇌안효낭구복2# bid,련속치료30d。관찰치료전후2조환자림상료효화신경공능결손(NDS)평분변화정황。결과:치료조현저진보솔(61.6%)급총진보솔(94.9%)균분별고우대조조현저진보솔(32.4%)급총진보솔(75.7%),량조차이유통계학의의(P<0.05)。량조치료후신경공능결손평분균하강,이치료조NDS평분하강우우대조조(P<0.05)。결론:뇌안효낭재치료중풍회복기기허혈어형료효긍정。
Objective:To observe Capsule treatment of brain stroke recovery clinical efficacy of qi and blood stasis type. Methods:stroke recovery QDBS 76 patients were randomly divided into treatment group and control group 39 cases of 37 cases, the control group received conventional symptomatic treatment, including anticoagulant, anti-platelet aggregation, cerebral protection, control blood sugar, blood pressure, etc. The treatment group received oral capsules while Naoan conventional treatment 2 # bid, continuous treatment 30d.Before and after treatment, and clinical efficacy of two groups of patients neurological deficit (NDS) score changes. Results:The rate of progress in the treatment group were significantly (61.6%) and total improvement rate ( 94.9%) , respectively, were significantly higher improvement rate ( 32.4% ) and total improvement rate ( 75.7% ).The difference was statistically significant (P <0.05).After treatment of neurological deficit scores were decreased. NDS score decreased in the treatment group than the control group (P <0.05).Conclusion Capsule in the treatment of cerebral stroke recovery QDBS more effective.